Trials / Completed
CompletedNCT03108963
L-carnitine and Metformin in Obese PCOS Women.
L-carnitine Plus Metformin in Clomiphene-resistant Obese PCOS Women, Reproductive and Metabolic Effects: a Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- Zagazig University · Other Government
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
L-carnitine and plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effect: a randomized clinical trial
Detailed description
the trial aims to compare L-carnitine and plus metformin in clomiphene-resistant obese PCOS women with placebo to state the reproductive and metabolic effects in form of pregnancy and insulin resistance parameters and lipid metabolism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-carnitine and Metformin | L-carnitine plus Metformin was given Obese PCOS Women trying induction of ovulation with clomiphene citrate. |
| DRUG | placebo | placebo was given Obese PCOS Women trying induction of ovulation with clomiphene citrate. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2017-04-11
- Last updated
- 2018-05-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03108963. Inclusion in this directory is not an endorsement.